PERK Inhibition Suppresses Neovascularization and Protects Neurons During Ischemia-Induced Retinopathy

Purpose Retinal ischemia is a common cause of a variety of eye diseases, such as retinopathy of prematurity, diabetic retinopathy, and vein occlusion. Protein kinase RNA-activated-like endoplasmic reticulum (ER) kinase (PERK), one of the main ER stress sensor proteins, has been involved in many diseases. In this study, we investigated the role of PERK in ischemia-induced retinopathy using a mouse model of oxygen-induced retinopathy (OIR). Methods OIR was induced by subjecting neonatal pups to 70% oxygen at postnatal day 7 (P7) followed by returning to room air at P12. GSK2606414, a selective PERK inhibitor, was orally administrated to pups right after they were returned to room air once daily until 1 day before sample collection. Western blot, immunostaining, and quantitative PCR were used to assess PERK phosphorylation, retinal changes, and signaling pathways in relation to PERK inhibition. Results PERK phosphorylation was prominently increased in OIR retinas, which was inhibited by GSK2606414. Concomitantly, PERK inhibition significantly reduced retinal neovascularization (NV) and retinal ganglion cell (RGC) loss, restored astrocyte network, and promoted revascularization. Furthermore, PERK inhibition downregulated the recruitment/proliferation of mononuclear phagocytes but did not affect OIR-upregulated canonical angiogenic pathways. Conclusions Our results demonstrate that PERK is involved in ischemia-induced retinopathy and its inhibition using GSK2606414 could offer an effective therapeutic intervention aimed at alleviating retinal NV while preventing neuron loss during retinal ischemia.

[1]  Huidong Shi,et al.  Single-cell transcriptome analyses reveal microglia types associated with proliferative retinopathy , 2022, JCI insight.

[2]  Zijing Huang,et al.  Ferulic acid alleviates retinal neovascularization by modulating microglia/macrophage polarization through the ROS/NF-κB axis , 2022, Frontiers in Immunology.

[3]  Yusen Liu,et al.  LGALS3BP in Microglia Promotes Retinal Angiogenesis Through PI3K/AKT Pathway During Hypoxia , 2022, Investigative ophthalmology & visual science.

[4]  A. Marneros,et al.  Role of inflammasome activation in neovascular age‐related macular degeneration , 2021, The FEBS journal.

[5]  E. Duh,et al.  Myeloid cell modulation by a GLP-1 receptor agonist regulates retinal angiogenesis in ischemic retinopathy , 2021, JCI insight.

[6]  G. Lederkremer,et al.  PERK Pathway and Neurodegenerative Disease: To Inhibit or to Activate? , 2021, Biomolecules.

[7]  T. Nakazawa,et al.  CHOP deletion and anti-neuroinflammation treatment with hesperidin synergistically attenuate NMDA retinal injury in mice. , 2021, Experimental eye research.

[8]  V. Sheffield,et al.  ATF4 leads to glaucoma by promoting protein synthesis and ER client protein load , 2020, Nature Communications.

[9]  V. Bunik,et al.  Suppressing endoplasmic reticulum stress-related autophagy attenuates retinal light injury , 2020, Aging.

[10]  M. Halliday,et al.  Targeting the kinase insert loop of PERK selectively modulates PERK signaling without systemic toxicity in mice , 2020, Science Signaling.

[11]  C. Hetz,et al.  Mechanisms, regulation and functions of the unfolded protein response , 2020, Nature Reviews Molecular Cell Biology.

[12]  O. Gorbatyuk,et al.  Endoplasmic reticulum stress: New insights into the pathogenesis and treatment of retinal degenerative diseases , 2020, Progress in Retinal and Eye Research.

[13]  Ye Sun,et al.  Targeting Neuroinflammation in Neovascular Retinal Diseases , 2020, Frontiers in Pharmacology.

[14]  Sharada H. Sharma,et al.  Morin supplementation modulates PERK branch of UPR and mitigates 1,2-dimethylhydrazine-induced angiogenesis and oxidative stress in the colon of experimental rats , 2020, Toxicology mechanisms and methods.

[15]  V. Roulstone,et al.  The PERK Inhibitor GSK2606414 Enhances Reovirus Infection in Head and Neck Squamous Cell Carcinoma via an ATF4-Dependent Mechanism , 2020, Molecular therapy oncolytics.

[16]  M. Motamedi,et al.  Neuronal Epac1 mediates retinal neurodegeneration in mouse models of ocular hypertension , 2020, The Journal of experimental medicine.

[17]  Xiaodong Cheng,et al.  Epac1 inhibition ameliorates pathological angiogenesis through coordinated activation of Notch and suppression of VEGF signaling , 2020, Science Advances.

[18]  Wenbo,et al.  Neuroprotective Effects of HSF1 in Retinal Ischemia-Reperfusion Injury , 2019, Investigative ophthalmology & visual science.

[19]  M. Grant,et al.  Molecular mechanisms of retinal ischemia. , 2019, Current opinion in physiology.

[20]  M. Sallese,et al.  PERK inhibition delays neurodegeneration and improves motor function in a mouse model of Marinesco-Sjögren syndrome , 2018, Human molecular genetics.

[21]  C. Hetz,et al.  Targeting PERK signaling with the small molecule GSK2606414 prevents neurodegeneration in a model of Parkinson's disease , 2018, Neurobiology of Disease.

[22]  M. Trese,et al.  Norrin treatment improves ganglion cell survival in an oxygen‐induced retinopathy model of retinal ischemia , 2017, Experimental eye research.

[23]  Yue Xu,et al.  Salubrinal attenuated retinal neovascularization by inhibiting CHOP-HIF1α-VEGF pathways , 2017, Oncotarget.

[24]  Xuezhi Zhou,et al.  Effects of GSK2606414 on cell proliferation and endoplasmic reticulum stress‑associated gene expression in retinal pigment epithelial cells. , 2017, Molecular medicine reports.

[25]  Jian-ru Li,et al.  Pharmacological Inhibition of PERK Attenuates Early Brain Injury After Subarachnoid Hemorrhage in Rats Through the Activation of Akt , 2017, Molecular Neurobiology.

[26]  D. Gao,et al.  PERK and XBP1 differentially regulate CXCL10 and CCL2 production , 2017, Experimental eye research.

[27]  M. Motamedi,et al.  Hydrogen Sulfide Contributes to Retinal Neovascularization in Ischemia-Induced Retinopathy , 2016, Investigative ophthalmology & visual science.

[28]  Z. Bebők,et al.  Limited ATF4 Expression in Degenerating Retinas with Ongoing ER Stress Promotes Photoreceptor Survival in a Mouse Model of Autosomal Dominant Retinitis Pigmentosa , 2016, PloS one.

[29]  P. Campochiaro,et al.  Molecular pathogenesis of retinal and choroidal vascular diseases , 2015, Progress in Retinal and Eye Research.

[30]  M. Halliday,et al.  PERK inhibition prevents tau-mediated neurodegeneration in a mouse model of frontotemporal dementia , 2015, Acta Neuropathologica.

[31]  X. Zhang,et al.  PERK pathway are involved in NO-induced apoptosis in endothelial cells cocultured with RPE under high glucose conditions. , 2014, Nitric oxide : biology and chemistry.

[32]  J. Corbett,et al.  PERK-Dependent Activation of JAK1 and STAT3 Contributes to Endoplasmic Reticulum Stress-Induced Inflammation , 2014, Molecular and Cellular Biology.

[33]  S. Fliesler,et al.  Endoplasmic reticulum stress and the unfolded protein responses in retinal degeneration. , 2014, Experimental eye research.

[34]  S. Lenna,et al.  Endoplasmic reticulum stress and endothelial dysfunction , 2014, IUBMB life.

[35]  B. Godley,et al.  TWEAK/Fn14 pathway is a novel mediator of retinal neovascularization. , 2014, Investigative ophthalmology & visual science.

[36]  U. Schmidt-Erfurth,et al.  Retinal pigment epithelium cells produce VEGF in response to oxidized phospholipids through mechanisms involving ATF4 and protein kinase CK2. , 2013, Experimental eye research.

[37]  V. Shinde,et al.  Modulation of angiogenesis by genetic manipulation of ATF4 in mouse model of oxygen-induced retinopathy [corrected]. , 2013, Investigative ophthalmology & visual science.

[38]  Li Liu,et al.  Targeting the IRE1α/XBP1 and ATF6 arms of the unfolded protein response enhances VEGF blockade to prevent retinal and choroidal neovascularization. , 2013, The American journal of pathology.

[39]  Brent M. Sanders,et al.  Characterization of a novel PERK kinase inhibitor with antitumor and antiangiogenic activity. , 2013, Cancer research.

[40]  L. Shewchuk,et al.  Discovery of 7-methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a potent and selective first-in-class inhibitor of protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK). , 2012, Journal of medicinal chemistry.

[41]  L. Kim,et al.  A brief history of anti-VEGF for the treatment of ocular angiogenesis. , 2012, The American journal of pathology.

[42]  A. Sreekumar,et al.  Arginase 2 deficiency reduces hyperoxia-mediated retinal neurodegeneration through the regulation of polyamine metabolism , 2012, Cell Death and Disease.

[43]  L. Glimcher,et al.  Differential Effects of Unfolded Protein Response Pathways on Axon Injury-Induced Death of Retinal Ganglion Cells , 2012, Neuron.

[44]  C. Hetz.  The unfolded protein response: controlling cell fate decisions under ER stress and beyond , 2012, Nature Reviews Molecular Cell Biology.

[45]  R. Ratan,et al.  Activation of Endoplasmic Reticulum Stress by Hyperglycemia Is Essential for Müller Cell–Derived Inflammatory Cytokine Production in Diabetes , 2012, Diabetes.

[46]  P. Walter,et al.  The Unfolded Protein Response: From Stress Pathway to Homeostatic Regulation , 2011, Science.

[47]  A. Yoshida,et al.  Hyperoxia therapy of pre-proliferative ischemic retinopathy in a mouse model. , 2011, Investigative ophthalmology & visual science.

[48]  R. Caldwell,et al.  Arginase 2 Deletion Reduces Neuro-Glial Injury and Improves Retinal Function in a Model of Retinopathy of Prematurity , 2011, PloS one.

[49]  D. Ron,et al.  The structure of the PERK kinase domain suggests the mechanism for its activation. , 2011, Acta crystallographica. Section D, Biological crystallography.

[50]  B. Lilly,et al.  Notch3 Is Critical for Proper Angiogenesis and Mural Cell Investment , 2010, Circulation research.

[51]  A. Salminen,et al.  Endoplasmic Reticulum Stress in Age-Related Macular Degeneration: Trigger for Neovascularization , 2010, Molecular medicine.

[52]  P. Hardy,et al.  Understanding ischemic retinopathies: emerging concepts from oxygen-induced retinopathy , 2010, Documenta Ophthalmologica.

[53]  A. Stahl,et al.  Computer-aided quantification of retinal neovascularization , 2009, Angiogenesis.

[54]  J. Wang,et al.  Endoplasmic reticulum stress is implicated in retinal inflammation and diabetic retinopathy , 2009, FEBS letters.

[55]  A. Di Polo,et al.  The role of lysophosphatidic acid receptor (LPA1) in the oxygen-induced retinal ganglion cell degeneration. , 2009, Investigative ophthalmology & visual science.

[56]  P. Walter,et al.  Signal integration in the endoplasmic reticulum unfolded protein response , 2007, Nature Reviews Molecular Cell Biology.

[57]  O. Barbash,et al.  The Oxidative Stressor Arsenite Activates Vascular Endothelial Growth Factor mRNA Transcription by an ATF4-dependent Mechanism* , 2005, Journal of Biological Chemistry.

[58]  D. Scheuner,et al.  Phosphorylation of the α Subunit of Eukaryotic Initiation Factor 2 Is Required for Activation of NF-κB in Response to Diverse Cellular Stresses , 2003, Molecular and Cellular Biology.

[59]  Peichuan Zhang,et al.  The PERK Eukaryotic Initiation Factor 2α Kinase Is Required for the Development of the Skeletal System, Postnatal Growth, and the Function and Viability of the Pancreas , 2002, Molecular and Cellular Biology.

[60]  D. Ron,et al.  Diabetes mellitus and exocrine pancreatic dysfunction in perk-/- mice reveals a role for translational control in secretory cell survival. , 2001, Molecular cell.

[61]  D. Ron,et al.  Perk is essential for translational regulation and cell survival during the unfolded protein response. , 2000, Molecular cell.

[62]  I. Pang,et al.  Role of C/EBP homologous protein in retinal ganglion cell death after ischemia/reperfusion injury. , 2014, Investigative ophthalmology & visual science.

[63]  V. Shinde,et al.  Modulation of Angiogenesis by Genetic Manipulation of ATF 4 in Mouse Model of Oxygen-Induced Retinopathy , 2014 .

[64]  M. Stewart.  The expanding role of vascular endothelial growth factor inhibitors in ophthalmology. , 2012, Mayo Clinic proceedings.

[65]  D. Scheuner,et al.  Phosphorylation of the alpha subunit of eukaryotic initiation factor 2 is required for activation of NF-kappaB in response to diverse cellular stresses. , 2003, Molecular and cellular biology.